Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MMP-3 -1171 5A/6A promoter polymorphism and cancer susceptibility: an updated meta-analysis and trial sequential analysis.

Future oncology (London, England) - 1 Jul 2023

Aziz Md Abdul, Jafrin Sarah, Barek Md Abdul, Anonna Shamima Nasrin, Islam Mohammad Safiqul

Abstract excerpt

Purpose: Previous studies of MMP-3 -1171 5A/6A in cancers have produced inconclusive outcomes. This updated meta-analysis was performed to clarify the link between this variant and cancer. Methods: Databases including PubMed, Google Scholar, EMBASE and Cochrane were searched for data collection. The associations were calculated by odds ratios with 95% CIs. Results: 63 eligible studies with 14,252 cases and 15,176...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Esophageal Neoplasms

Share to Genetic Predisposition to Disease

Share to Matrix Metalloproteinase 3

Share to Polymorphism, Genetic

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 37551683
DOI: 10.2217/fon-2022-1306

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MMP-3 -1171 5A/6A promoter polymorphism and cancer susceptibility: an updated meta-analysis and trial sequential analysis.PMID 37551683Read ↗

Association of matrix metalloproteinase-3 -1171(5A>6A) polymorphism with cancer risk: a meta-analysis of 41 studies.Semantic proximity Read ↗

Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.Semantic proximity Read ↗

Common polymorphism in the MMP-13 gene may contribute to the risk of human cancers: a meta-analysis.Semantic proximity Read ↗

The polymorphism MMP1 -1607 (1G>2G) is associated with a significantly increased risk of cancers from a meta-analysis.Semantic proximity Read ↗

Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.Semantic proximity Read ↗

Meta-analysis of associations between polymorphisms in the promoter regions of matrix metalloproteinases and the risk of colorectal cancer.Semantic proximity Read ↗

Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.Semantic proximity Read ↗

Matrix metalloproteinase-2 -1306 C>T gene polymorphism is associated with reduced risk of cancer: a meta-analysis.Semantic proximity Read ↗

Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.Semantic proximity Read ↗

Current evidence on associations between the MMP-7 (-181A>G) polymorphism and digestive system cancer risk.Semantic proximity Read ↗

Matrix metalloproteinase variants associated with risk and clinical outcome of esophageal cancer.Semantic proximity Read ↗

Update meta-analysis on MMP-7 -181A>G polymorphism and cancer risk: evidence from 25 studies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.